Skip to search formSkip to main contentSkip to account menu

Neurokinin-1 Receptor Antagonists

Known as: Receptor Blockers, Neuroleukin-1, Receptor Antagonists, Neurokinin-1, Neurokinin 1 Receptor Antagonists 
Compounds that inhibit or block the activity of NEUROKININ-1 RECEPTORS.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Chemotherapy-induced nausea and vomiting (CINV) is a serious adverse effect of chemotherapy that limits patients' physical… 
2009
2009
3-[(3aR,4R,5S,7aS)-5-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-4-(4-fluorophenyl)octahydro-2H-isoindol-2-yl]cyclopent-2-en… 
2009
2009
Coordinated microtubule polymerization and depolymerization is essential for numerous biological functions, including mitotic… 
2007
2007
A series of bifunctional peptides that act as agonists for delta and mu opioid receptors with delta selectivity and as antagonist… 
Review
2004
Review
2004
The peptide substance P and its tachykinin receptor, neurokinin-1 (NK1), have been the focus of considerable research for their… 
2004
2004
Neurokinin-1 (NK-1) receptor antagonists are a new class of antiemetic agents that have activity in controlling cisplatin-induced… 
Review
2004
Review
2004
Chemotherapy-induced nausea and vomiting (CINV) is associated with a significant deterioration in quality of life, and although… 
2001
2001
Abstract: Systemic exposure to neurokinin‐1 receptor antagonists CP099994 or LY306740 prior to cocaine administration (10 mg/kg i…